Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma
Fianlimab(一种人淋巴细胞活化基因-3 (LAG-3) 单克隆抗体)联合 Cemiplimab 治疗晚期黑色素瘤的 I 期研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02172
Hamid, Omid; Lewis, Karl D; Weise, Amy; McKean, Meredith; Papadopoulos, Kyriakos P; Crown, John; Kim, Tae Min; Lee, Dae Ho; Thomas, Sajeve S; Mehnert, Janice; Kaczmar, John; Lakhani, Nehal J; Kim, Kevin B; Middleton, Mark R; Rabinowits, Guilherme; Spira, Alexander I; Yushak, Melinda; Mehmi, Inderjit; Fang, Fang; Chen, Shuquan; Mani, Jayakumar; Jankovic, Vladimir; Wang, Fang; Fiaschi, Nathalie; Brennan, Laura; Paccaly, Anne; Masinde, Sheila; Salvati, Mark; Fury, Matthew G; Kroog, Glenn; Lowy, Israel; Gullo, Giuseppe